Identification of CD49a+ CD8+ resident memory T cells in vitiligo‐like lesions associated with nivolumab treatment for melanoma
- 30 September 2019
- journal article
- letter
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 34 (2) , e79-e82
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 8 references indexed in Scilit:
- Formation and phenotypic characterization of CD49a, CD49b and CD103 expressing CD8 T cell populations in human metastatic melanomaOncoImmunology, 2018
- Tissue-resident memory T cells at the center of immunity to solid tumorsNature Immunology, 2018
- Resident memory T cells in the skin mediate durable immunity to melanomaScience Immunology, 2017
- CD49a Expression Defines Tissue-Resident CD8 + T Cells Poised for Cytotoxic Function in Human SkinImmunity, 2017
- Correlation between vitiligo occurrence and clinical benefit in advanced melanoma patients treated with nivolumab: A multi‐institutional retrospective studyThe Journal of Dermatology, 2016
- Upregulation of granzyme B and interferon‐γ mRNA in responding lesions by treatment with nivolumab for metastatic melanoma: a case reportJournal of the European Academy of Dermatology and Venereology, 2016
- Immune-related adverse events with immune checkpoint blockade: a comprehensive reviewEuropean Journal of Cancer, 2016
- Vitiligo-Like Depigmentation in Patients With Stage III-IV Melanoma Receiving Immunotherapy and Its Association With Survival: A Systematic Review and Meta-AnalysisJournal of Clinical Oncology, 2015